TECHNOLOGY: Cell Culture
CYTOPILOT® Fluidised Bed Reactor
 |
Cytopilot® is a fluidised bed reactor for cultivation of
any kind of cells, especially animal derived ones. The patented modular design permits high
flexibility, therefore various applications can be realised. Cytopilot® provides a controlled, fluidised bed, perfusion environment from laboratory scale to production scale. Advantages
With the Cytopilot® concept you gain: minimised nutrient gradients minimal risk of contamination sufficient oxygen supply high unit cell density and productivity low shearing stress easy scale-up Application
The main application areas of the Cytopilot® fluidised bed reactors are the production of recombinant proteins and monoclonal
antibodies. Current researches deal also with the production of vaccines, gene
therapy and stem cell expansion. Several concrete examples are mentioned in the
reference list.
|
|
Cytopilot® fluidised bed reactor was developed by IAM, the Institute of Applied Microbiology of the University of Agricultural Sciences in Vienna, Austria, and is designed and manufactured by Vogelbusch. The laboratory scale reactor Cytopilot® Mini is distributed by Amersham Bioscieneces/GE Healthcare. The relationship between Amersham/GE, IAM and Vogelbusch ensures comprehensive technical support, advice and service at all levels of a scale-up project, for both system and media. |
BACK TO
TECHNOLOGY 
HOME